CVE-2026-18531: IBM Maximo Application Suite · Weak Randomness
Affects IBM Maximo Application SuiteSource CVE Database V5
Not known to be exploited · CVSS 5.3 Medium.
Data as of 3 Nov 2026, 22:58 UTC
- EPSS
- 0.3% chance of exploitation in 30 days – higher than 31% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:NExploitation evidence
Disclosed: evidence found.
CVE published 5 Aug 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 3 Nov 2026.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| IBMMaximo Application Suite | Affected
| Fixed in– |
CPE configurations (6)
cpe:2.3:a:ibm:maximo_application_suite:9.2:*:*:*:*:*:*:*cpe:2.3:a:ibm:maximo_application_suite:9.2.0:*:*:*:*:*:*:*cpe:2.3:a:ibm:maximo_application_suite:9.1:*:*:*:*:*:*:*cpe:2.3:a:ibm:maximo_application_suite:9.1.0:*:*:*:*:*:*:*cpe:2.3:a:ibm:maximo_application_suite:9.0:*:*:*:*:*:*:*cpe:2.3:a:ibm:maximo_application_suite:9.0.0:*:*:*:*:*:*:*
AI-suggested
Until an official fix is available, monitor IBM's security advisories for updates. No specific mitigation steps are provided at this time.
Description
IBM Maximo Application Suite versions 9.0, 9.1, and 9.2 contain a vulnerability where a weak HMAC session signing secret is used. This weakness could allow a remote attacker to tamper with session data. The vulnerability is identified as CWE-330, indicating the use of insufficiently random values. The CVSS 3.1 base score is 5.3, reflecting a medium severity level. There is no vendor advisory or patch information currently available, and no known exploits in the wild have been reported.